| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |